Clinical research

Systemic endothelin receptor blockade in ST-segment elevation acute coronary syndrome protects the microvasculature: a randomised pilot study

EuroIntervention 2012;7:1386-1395. DOI: 10.4244/EIJV7I12A218

Christopher Adlbrecht
Christopher Adlbrecht1, MD, MBA; Martin Andreas2, MD, MBA; Bassam Redwan1, MD; Klaus Distelmaier1, MD; Julia Mascherbauer1, MD; Alexandra Kaider3, MSc; Michael Wolzt4, MD; Ioana-Alexandra Tilea1, Thomas Neunteufl1, MD; Georg Delle-Karth1, MD; Gerald Maurer1, MD; Irene M. Lang1*, MD
1. Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria; 2. Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria; 3. Center for Medical Statistics, Informatics

Aims: ST-elevation acute coronary syndrome (STE-ACS) is characterised by compromised blood flow at the epicardial and microvascular levels. Endo

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

acute myocardial infarctionendothelinbq-123percutaneous coronary interventionreperfusion
Read next article
Pre-infarction angina predicts thrombus burden in patients admitted for ST-segment elevation myocardial infarction

Latest news